文献速递艾滋病与性传播感染细菌感染、耐药与抗菌药物

尼日利亚婴儿HIV-1亚型与耐药突变关联研究

Association between HIV-1 subtype and drug resistance in Nigerian infants.
PubMed 文献 · J Antimicrob Chemother · 2019-01-01

结果显示不同亚型间监测耐药突变存在差异,GWA-II/GCA亚分支相比CRF02_AG更常见67N、70R、184I/V及胸苷类似物突变。

要点

  • 尼日利亚婴儿中以CRF02_AG(41.0%)和GWA-I(30.2%)亚型最常见。
  • 44.8%婴儿携带≥1个NNRTI突变,21.7%携带≥1个NRTI突变。
  • GWA-II/GCA亚分支的NRTI耐药突变风险显著高于CRF02_AG。

核心结论

  • 尼日利亚婴儿HIV-1监测耐药突变在不同亚型间存在差异,尤其GWA-II和GCA亚分支与CRF02_AG和GWA-I相比差异明显。

研究设计与样本

  • 采用Fisher精确检验和逻辑回归分析评估亚型与监测耐药突变的关联,并控制地理区域和暴露因素。

主要发现

  • 最常见亚型为CRF02_AG(174例,41.0%)、GWA-I(128例,30.2%)、GWA-II(24例,5.7%)、GCA(11例,2.6%)、A(21例,5.0%)和CRF06_cpx(18例,4.2%)。
  • 逻辑回归显示GWA-II/GCA相比CRF02_AG,67N更常见(OR 12.0,P=0.006),70R更常见(OR 23.1,P=0.007),184I/V更常见(OR 2.92,P=0.020)。
  • GWA-II/GCA相比CRF02_AG,≥1个胸苷类似物突变更常见(OR 3.87,P=0.014),≥1个2型胸苷类似物突变更常见(OR 7.61,P=0.001),≥1个NRTI突变更常见(OR 3.26,P=0.005)。

临床怎么用

  • 在尼日利亚婴儿HIV耐药监测中应考虑亚型分布对耐药突变模式的影响。
  • 对GWA-II和GCA亚分支感染的婴儿需关注NRTI类耐药突变的更高风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Many lines of evidence point to HIV-1 subtype-specific differences in the development of drug resistance mutations. While variation between subtype C and others has been extensively explored, there has been less emphasis on subtypes common to West Africa. We examined a previously described national survey of pretreatment drug resistance in HIV-1-infected Nigerian children aged <18 months, to explore the association between subtypes and patterns of resistance. METHODS: Five hundred and forty-nine dried blood spots, from 15 early infant diagnostic facilities in Nigeria, were amplified and HIV-1 polymerase was sequenced. Four hundred and twenty-four were analysed for surveillance drug resistance mutations (SDRMs). Associations between subtype and SDRMs were evaluated by Fisher's exact test and logistic regression analysis, controlling for geographical region and exposure. RESULTS: Using the sub-subtypes of HIV-1 G defined by Delatorre et al. (PLoS One 2014. 9: e98908) the most common subtypes were CRF02_AG (174, 41.0%), GWA-I (128, 30.2%), GWA-II (24, 5.7%), GCA (11, 2.6%), A (21, 5.0%) and CRF06_cpx (18, 4.2%). One hundred and ninety infants (44.8%) had ≥1 NNRTI mutation, 92 infants (21.7%) had ≥1 NRTI mutation and 6 infants (1.4%) had ≥1 PI mutation. By logistic regression, 67N was more common in GWA-II/GCA than CRF02_AG (OR 12.0, P = 0.006), as was 70R (OR 23.1, P = 0.007), 184I/V (OR 2.92, P = 0.020), the presence of ≥1 thymidine analogue mutation (TAM) (OR 3.87, P = 0.014), ≥1 type 2 TAM (OR 7.61, P = 0.001) and ≥1 NRTI mutation (OR 3.26, P = 0.005). CONCLUSIONS: This dataset reveals differences among SDRMs by subtype; in particular, between the GWA-II and GCA subclades, compared with CRF02_AG and GWA-I.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Chaplin B, Akanmu AS, Inzaule SC, et al. Association between HIV-1 subtype and drug resistance in Nigerian infants. J Antimicrob Chemother. 2019. PMID: 30260417. doi:10.1093/jac/dky380

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。